Gilead prices COVID-19 drug remdesivir at $2,340 per patient in developed nationsRemdesivir is expected to be in high demand as one of the only treatments so far shown to alter the course of COVID-19Latest UpdatesCOVID-19 Updates By Reuters On Jun 30, 2020 Representational image 0 4,277 Share
